Greencoat Renewables

Change of Company Secretary & Appointment of SID

RNS Number : 8625N
Greencoat Renewables PLC
27 September 2019
 

 

 

 

Change of Company Secretary and

Appointment of Senior Independent Director

 

Dublin, London, 27 September 2019: Greencoat Renewables PLC, the Irish renewable infrastructure company, announces the resignation of Andrea Finegan as Company Secretary with immediate effect after holding the position since Admission.

 

Ronan Murphy, Chairman said "I would like to thank Andrea, on behalf of the Board, for the very significant role she has played in the development of Greencoat Renewables PLC and wish Andrea well for the future".

 

Estera Administration (UK) Limited, who has been acting as Assistant Company Secretary since 25 January 2018, will now assume the role of Company Secretary.

                                              

The Board is also pleased to announce that Emer Gilvarry has been appointed Senior Independent Director with immediate effect. Emer, an independent Non-Executive Director since Admission, is also Chair of the Remuneration Committee and a member of the Audit Committee, Management Engagement Committee and Nomination Committee.

 

--- ENDS ---

 

For further details contact:

Greencoat Capital LLP (Investment Manager)

 

 

 

 

 

Bertrand Gautier

Paul O' Donnell

Tom Rayner





+44 20 7832 9400

 

 

 

 

 

 

 

 

 

 

 

 

 

FTI Consulting (Investor Relations & Media)

 

 

 

 

 

 

 

Jonathan Neilan

 

 

 

 

+353 1 765 0886

Melanie Farrell

 

 

 

 

[email protected]

 

Davy (Broker, NOMAD and Euronext Growth Adviser)

Fergal Meegan

Barry Murphy

Ronan Veale

 

 

 

 

 

+353 1 679 6363

 

 

 

 

RBC Capital Markets (Joint Broker)

Matthew Coakes

Jonathan Hardy

 

 

 

 

+44 20 7653 4000

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
COSPGUUUBUPBGQQ